Cuproptosis combines immune landscape providing prognostic biomarker in head and neck squamous carcinoma

Head and neck squamous carcinomas (HNSC) are the seventh most common cancer around the world. Treatment options available today have considerable limitations in terms of efficacy. Identifying novel therapeutic targets for HNSC is, therefore, urgently needed. As a novel determined regulated cell deat...

Full description

Bibliographic Details
Main Authors: Tingting Shu, Xudong Wang
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023027019